Your browser is no longer supported. Please, upgrade your browser.
TFX [NYSE]
Teleflex Incorporated
IndexS&P 500 P/E33.74 EPS (ttm)9.16 Insider Own0.10% Shs Outstand46.81M Perf Week-3.10%
Market Cap14.98B Forward P/E21.70 EPS next Y14.24 Insider Trans-31.23% Shs Float46.66M Perf Month-11.06%
Income434.30M PEG3.07 EPS next Q4.50 Inst Own94.10% Short Float1.36% Perf Quarter-21.30%
Sales2.76B P/S5.43 EPS this Y-27.60% Inst Trans-0.02% Short Ratio2.04 Perf Half Y-21.28%
Book/sh78.14 P/B3.95 EPS next Y7.33% ROA6.10% Target Price442.44 Perf Year-16.74%
Cash/sh9.93 P/C31.13 EPS next 5Y11.00% ROE12.50% 52W Range304.57 - 449.38 Perf YTD-24.93%
Dividend1.36 P/FCF29.87 EPS past 5Y7.60% ROI6.90% 52W High-31.25% Beta1.06
Dividend %0.44% Quick Ratio1.90 Sales past 5Y7.00% Gross Margin54.90% 52W Low1.44% ATR9.81
Employees14000 Current Ratio2.70 Sales Q/Q11.50% Oper. Margin20.10% RSI (14)29.61 Volatility2.64% 2.98%
OptionableYes Debt/Eq0.56 EPS Q/Q70.70% Profit Margin15.70% Rel Volume1.28 Prev Close305.15
ShortableYes LT Debt/Eq0.53 EarningsOct 28 BMO Payout14.70% Avg Volume310.85K Price308.95
Recom2.00 SMA20-8.80% SMA50-14.04% SMA200-21.06% Volume396,610 Change1.25%
Oct-07-21Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Sep-07-21Resumed Raymond James Outperform $440
Jul-19-21Downgrade SVB Leerink Outperform → Mkt Perform $410
Jan-06-21Reiterated Needham Buy $406 → $445
Nov-02-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $382
Jan-31-20Reiterated Needham Buy $408 → $423
Aug-02-19Reiterated Needham Buy $325 → $403
Jun-11-19Initiated Wells Fargo Outperform $345
Apr-24-19Downgrade Needham Strong Buy → Buy $325
Feb-22-19Reiterated Needham Strong Buy $300 → $325
Oct-16-18Initiated Barclays Equal Weight $266
Sep-10-18Upgrade Needham Buy → Strong Buy $279 → $300
Aug-03-18Reiterated Needham Buy $298 → $279
May-14-18Reiterated Needham Buy $293 → $298
May-04-18Reiterated Needham Buy $285 → $293
Apr-04-18Initiated Goldman Neutral $257
Nov-10-17Resumed Piper Jaffray Overweight $295
Nov-03-17Reiterated Needham Buy $237 → $285
Sep-08-17Upgrade Leerink Partners Mkt Perform → Outperform
Sep-06-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-29-21 11:17AM  
Nov-26-21 06:00PM  
Nov-18-21 06:45AM  
06:30AM  
Nov-15-21 08:52AM  
Nov-04-21 06:30AM  
Nov-03-21 03:02PM  
06:48AM  
Oct-29-21 10:24AM  
06:30AM  
Oct-28-21 05:00PM  
08:35AM  
06:45AM  
06:30AM  
Oct-27-21 06:30AM  
Oct-21-21 03:03PM  
Oct-18-21 05:18AM  
Oct-14-21 06:30AM  
Sep-28-21 01:20PM  
Sep-14-21 06:30AM  
Sep-13-21 08:17AM  
Sep-09-21 06:30AM  
Sep-01-21 06:30AM  
Aug-30-21 06:30AM  
Aug-26-21 11:21AM  
06:30AM  
Aug-17-21 10:13AM  
Jul-30-21 10:28AM  
Jul-29-21 08:02PM  
07:45AM  
06:45AM  
06:30AM  
Jul-22-21 03:03PM  
Jul-19-21 08:21AM  
07:09AM  
Jul-16-21 05:24AM  
Jul-15-21 01:48PM  
09:49AM  
06:30AM  
Jul-09-21 06:30AM  
Jul-06-21 09:48AM  
06:30AM  
Jun-28-21 05:00PM  
Jun-24-21 08:11AM  
Jun-16-21 06:30AM  
Jun-14-21 10:30AM  
Jun-07-21 06:30AM  
Jun-03-21 11:46AM  
May-24-21 09:25AM  
May-18-21 10:08AM  
06:55AM  
06:30AM  
May-11-21 06:30AM  
May-03-21 04:30PM  
06:30AM  
Apr-30-21 10:22AM  
Apr-29-21 08:05AM  
06:30AM  
Apr-27-21 06:30AM  
Apr-23-21 07:52AM  
Apr-22-21 12:33PM  
Apr-15-21 06:30AM  
Apr-14-21 12:18PM  
Apr-12-21 06:10PM  
Apr-01-21 09:06AM  
Mar-27-21 11:31AM  
Mar-11-21 02:00AM  
Mar-10-21 06:30AM  
Mar-09-21 06:30AM  
Mar-02-21 07:35AM  
Feb-26-21 10:16AM  
Feb-25-21 09:00PM  
06:45AM  
06:30AM  
Feb-24-21 06:30AM  
Feb-23-21 06:30AM  
Feb-17-21 06:30AM  
Feb-16-21 06:30AM  
06:30AM  
Feb-11-21 06:30AM  
Jan-28-21 04:04AM  
Jan-20-21 06:30AM  
Jan-19-21 06:30AM  
Jan-04-21 06:30AM  
Dec-30-20 08:04AM  
Dec-29-20 06:01AM  
Dec-28-20 05:22PM  
05:00PM  
Dec-15-20 02:24PM  
Dec-08-20 12:26PM  
Dec-03-20 06:30AM  
Dec-02-20 05:14AM  
Nov-19-20 06:30AM  
Nov-17-20 10:03AM  
Nov-03-20 08:29AM  
Nov-02-20 11:29AM  
06:30AM  
Oct-29-20 07:45AM  
07:45AM  
06:45AM  
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology product comprises the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hicks Cameron PCorp. VP & Chief HR OfficerNov 10Option Exercise121.003,600435,60012,204Nov 12 04:36 PM
Hicks Cameron PCorp. VP & Chief HR OfficerNov 10Sale350.003,6001,260,0008,604Nov 12 04:36 PM
Kelly LiamChairman, President & CEOAug 18Option Exercise59.758,987536,97334,762Aug 20 04:46 PM
Kelly LiamChairman, President & CEOAug 18Sale376.328,9873,381,97325,775Aug 20 04:46 PM
Klasko Stephen K. M.D.DirectorJul 12Option Exercise59.753,564212,9494,988Jul 13 09:12 PM
Klasko Stephen K. M.D.DirectorJul 12Sale422.553,5641,505,9681,424Jul 13 09:12 PM
Hicks Cameron PCorp. VP & Chief HR OfficerJun 10Option Exercise111.413,476387,27712,080Jun 11 06:08 PM
Hicks Cameron PCorp. VP & Chief HR OfficerJun 10Sale395.863,4761,375,9968,604Jun 11 06:08 PM
RANDLE STUART ADirectorJun 04Option Exercise59.753,564212,9496,762Jun 08 05:03 PM
RANDLE STUART ADirectorJun 04Sale395.662,384943,2534,199Jun 08 05:03 PM
Hicks Cameron PCorp. VP & Chief HR OfficerMar 15Option Exercise103.073,326342,80611,604Mar 17 05:30 PM
Hicks Cameron PCorp. VP & Chief HR OfficerMar 15Sale421.013,0001,263,0408,604Mar 17 05:30 PM
Leyden James JVP, General Counsel, SecretaryDec 28Option Exercise99.0125,9962,573,83541,502Dec 29 06:49 PM
Hicks Cameron PCorp. VP, HR & CommunicationsDec 02Option Exercise110.261,088119,9599,245Dec 02 05:02 PM